Prologis Ventures’ investment in the round has helped the warehouse rental service provider push its overall funding to more than $143m.

Roblox has bought the intellectual property assets of the Gresham Lehrman Group-backed recruitment test developer as it prepares to go public.

Cancer and graft-versus-host disease therapy developer MaaT has raised a second tranche to hike the Biocodex-backed round to $30.4m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GV was among the participants in the healthcare management platform developer's third round this year, valuing it at $1.5bn.

The diabetes treatment developer, which counts Tasly and Legend Star among its investors, has received what it referred to as pre-IPO funding.

The business management software provider's Zhongnan Capital-backed series D round lifted its overall funding to about $165m.

The $59.4m round will support the development of four clinical-stage candidates for neurological disorders Noema licensed from shareholder Roche.

The gene-editing drug developer has completed its first publicly announced round, with Alphabet unit GV the only disclosed participant.

The Croda International-backed biopharmaceutical developer has cloesd a $13.2m round to boost its overall funding to about $25m.